These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1266475)

  • 1. [Treatment of amyotrophic lateral sclerosis with ribonucleotides].
    Bunina TL; Khondkarian OA; Korshunova TS; Larskiĭ EG; Fuks BB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(2):166-74. PubMed ID: 1266475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of myopathies with ribonucleotides].
    Grinio LP; Korabel'nikova NI; Shabanova ME; Medvedev MI; Islamova IB; Bobrova KF
    Sov Med; 1991; (8):91. PubMed ID: 1763382
    [No Abstract]   [Full Text] [Related]  

  • 3. [Myelin toxicity of the serum of patients with amyotrophic lateral sclerosis in nerve tissue cultures].
    Viktorov IV; Bunina TL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(7):984-90. PubMed ID: 567414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of a long-term dynamic observation of the use of the ENKAD preparation in pigment tapetoretinal abiotrophy].
    Katsnel'son LA; Trutneva KV; Bogoslovskiĭ AI; Miliavskaia TI; Sadykov IuKh
    Vestn Oftalmol; 1982; (2):28-30. PubMed ID: 7043877
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental validation of the use of RNA hydrolysate (ENKAD) in chemical burns of the cornea].
    Andrushkova OA; Plevinskikh VP; Iakimenko SA
    Oftalmol Zh; 1990; (6):338-43. PubMed ID: 2100776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyotrophic lateral sclerosis an enigmatic disease with B-cellular and anti-retroviral immune responses.
    Westarp ME; Fuchs D; Bartmann P; Hoff-Jörgensen R; Clausen J; Wachter H; Kornhuber HH
    Eur J Med; 1993; 2(6):327-32. PubMed ID: 8252177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment results using the preparation ENKAD in patients with peripheral tapetoretinal abiotrophy].
    Katsnel'son LA; Maslova-Khoroshilova IP; Eliseeva RF; Dnestrova GI
    Vestn Oftalmol; 1988; 104(6):54-61. PubMed ID: 3242209
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dynamics of clinical, immunologic and cytologic indices in the treatment of Sjögren's disease with the preparation ENKAD].
    Makarova OV; Pozharitskaia MM; Kop'eva TN; Fuks BB; Shabanova ME
    Revmatologiia (Mosk); 1988; (4):56-61. PubMed ID: 3073502
    [No Abstract]   [Full Text] [Related]  

  • 10. Interleukin-1beta converting enzyme/Caspase-1 (ICE/Caspase-1) and soluble APO-1/Fas/CD 95 receptor in amyotrophic lateral sclerosis patients.
    Iłzecka J; Stelmasiak Z; Dobosz B
    Acta Neurol Scand; 2001 Apr; 103(4):255-8. PubMed ID: 11328198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of amyotrophic lateral sclerosis with thyrotropin releasing hormone].
    Serratrice G; Desnuelle C; Crevat A; Guelton C; Meyer-Dutour A
    Rev Neurol (Paris); 1986; 142(2):133-9. PubMed ID: 3088700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: the effect of riluzole treatment.
    Andreadou E; Kapaki E; Kokotis P; Paraskevas GP; Katsaros N; Libitaki G; Zis V; Sfagos C; Vassilopoulos D
    Clin Neurol Neurosurg; 2008 Mar; 110(3):222-6. PubMed ID: 18055102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amino acid metabolism in lateral amyotrophic sclerosis].
    Pivovarova VM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1971; 71(8):1169-73. PubMed ID: 5136822
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical, electrophysiologic and endocrine effects of the perfusion of high doses of TRH in amyotrophic lateral sclerosis].
    Gueguen B; Puymirat J; Grouselle D; Piketty ML; Bleton JP; Bourdel MC; Rondot P
    Rev Neurol (Paris); 1988; 144(11):704-9. PubMed ID: 3148186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anomaly in the neurotransmitter amino acids in amyotrophic lateral sclerosis: a therapeutic application].
    Blin O; Desnuelle C; Guelton C; Aubrespy G; Ardissonne JP; Crevat A; Pouget J; Serratrice G
    Rev Neurol (Paris); 1991; 147(5):392-4. PubMed ID: 1677212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Attempts at treatment of amyotrophic lateral sclerosis].
    Domzal T; Ilnicki S
    Wiad Lek; 1974 Jun; 27(11):955-7. PubMed ID: 4839886
    [No Abstract]   [Full Text] [Related]  

  • 17. [Calcitonin level in cerebrospinal fluid of patients with amyotrophic lateral sclerosis].
    Klimek A; Stepień H; Szulc-Kuberska J; Pisarek H
    Pol Tyg Lek; 1992 Apr 6-13; 47(14-15):310-1. PubMed ID: 1437739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled study of reverse transcriptase in serum and CSF of HIV-negative patients with ALS.
    MacGowan DJ; Scelsa SN; Imperato TE; Liu KN; Baron P; Polsky B
    Neurology; 2007 May; 68(22):1944-6. PubMed ID: 17536052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum CNTF level in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Eur Cytokine Netw; 2003; 14(3):192-4. PubMed ID: 14656696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortical plasticity in amyotrophic lateral sclerosis: motor imagery and function.
    Lulé D; Diekmann V; Kassubek J; Kurt A; Birbaumer N; Ludolph AC; Kraft E
    Neurorehabil Neural Repair; 2007; 21(6):518-26. PubMed ID: 17476000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.